The American Society of Breast Surgeons just released the Breast Surgery Checklist to advance perioperative patient safety. We are proud of Dr. Ted A. James' endeavors and leadership in creating this useful tool.
The Checklist is designed for breast surgeons to help ensure quality throughout the perioperative period. This tool is intended to facilitate surgical process management and elevate patient care. It is structured into two key segments:
Before Start of Surgery
Before Closure
We are happy to announce that our research fellow, Dr. Estefania Roldan, recently matched at Beth Israel Deaconess Medical Center for her General Surgery Residency.
Dr. Roldan's dedication, hard work, and passion for medicine have truly paid off as she embarks on this exciting journey to further her career in surgery. We extend our heartfelt best wishes to her as she begins this new professional chapter.
After months of hard work, dedication, and rigorous research, our team has reached a significant milestone - our research paper, Discordant Pathologic Response in the Breast and Axilla to Neoadjuvant Chemotherapy, has been accepted for publication in the prestigious academic journal "Annals of Surgical Oncology".
The use of neoadjuvant chemotherapy (NAC) has increased over time due to its effectiveness in turning inoperable tumors operable, reducing the morbidity of surgery, de-escalating surgery, and functioning as a prognostic tool. Although the use of NAC is the cornerstone treatment for patients diagnosed with node-positive breast cancer, we observed that there is a particular group whose primary breast tumor responds while the nodal disease does not, which we have termed as a discordant response. In our manuscript, Discordant Pathologic Response in the Breast and Axilla to Neoadjuvant Chemotherapy, we identified patient demographic factors and clinicopathologic implications that promote a discordant response between breast and axillary nodes after NAC.
